Help
RSS
API
Feed
Maltego
Contact
Domain > www.advate.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2021-02-08
143.204.226.90
(
ClassC
)
2023-06-26
18.154.227.19
(
ClassC
)
2024-02-17
99.84.66.30
(
ClassC
)
2024-12-13
65.8.161.20
(
ClassC
)
2025-03-07
99.84.66.79
(
ClassC
)
2025-03-24
99.84.66.116
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyServer: CloudFrontDate: Sat, 17 Feb 2024 19:07:32 GMTContent-Type: text/htmlContent-Length: 167Connection: keep-aliveLocation: https://www.advate.com/X-Cache: Redirect fr html>head>title>301 Moved Permanently/title>/head>body>center>h1>301 Moved Permanently/h1>/center>hr>center>CloudFront/center>/body>/html>
Port 443
HTTP/1.1 200 OKContent-Type: text/html; charsetutf-8Content-Length: 39611Connection: keep-aliveDate: Sat, 17 Feb 2024 19:07:33 GMTSet-Cookie: AWSALBFKNc8ceY36dy/gBIS7j4RHbPdVUFCMoNSfr7vu+z9HvyfOkXEweV !DOCTYPE html>html>head> !-- OneTrust Cookies Consent Notice start for advate.com --> script typetext/javascript srchttps://cdn.cookielaw.org/consent/3d0b41dd-edb4-41dd-a6e0-9c09e103676b/OtAutoBlock.js>/script> script srchttps://cdn.cookielaw.org/scripttemplates/otSDKStub.js typetext/javascript charsetUTF-8 data-domain-script3d0b41dd-edb4-41dd-a6e0-9c09e103676b>/script> script typetext/javascript> function OptanonWrapper() { } /script>!-- OneTrust Cookies Consent Notice end for advate.com --> meta charsetutf-8 /> meta http-equivX-UA-Compatible contentIEedge> meta nameviewport contentwidthdevice-width, initial-scale1.0> meta nameformat-detection contenttelephoneno> meta namefacebook-domain-verification contentnr581u3xamt2j5c49gth96yz62kmh5 /> title>Hemophilia A Treatment – ADVATE® Antihemophilic Factor (Recombinant) Official Site./title>meta namedescription contentADVATE® Antihemophilic Factor (Recombinant) is a treatment for hemophilia A, a factor VIII deficiency. See Detailed Important Risk Information and full Prescribing Information. />meta propertyog:title contentADVATE® [Antihemophilic Factor (Recombinant)] />meta propertyog:url contenthttps://www.advate.com/ />meta propertyog:description contentPlease see the ADVATE® [Antihemophilic Factor (Recombinant)] Detailed Important Risk Information and full Prescribing Information. />meta propertyog:type contentWebsite />meta propertyog:image contenthttps://www.advate.com/Content/images/og-image.jpg />meta propertyfb:app_id content580706625782061 />meta propertyog:site_name contentADVATE />link relcanonical hrefhttps://www.advate.com /> script typeapplication/ld+json> {@context: http://schema.org, @type: MedicalWebPage, audience: https://health-lifesci.schema.org/Patient, specialty: https://health-lifesci.schema.org/Hematologic, url: https://www.advate.com/, description: Hemophilia A Treatment - ADVATE® Offic
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]